Claudio Giacinto Atene

7PUBLICATIONS
20CO-AUTHORS
Haematological tumoursMolecular targetsAutoimmunityAllergyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 10, 2023
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting.

Claudia Sorbi, Silvia Belluti, Claudio Giacinto Atene

|Jul 09, 2022
In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus.

Roberta Lotti, Claudio Giacinto Atene, Emma Dorotea Zanfi

|Mar 25, 2022
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity.

Vincenzo Nasillo, Ivana Lagreca, Daniela Vallerini

|Feb 24, 2021
IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Rossana Maffei, Stefania Fiorcari, Stefania Benatti

Pageof 2